Antiva Biosciences, Inc.

Amendment
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Aug 28, 2017
Total Offering

$25,941,512

Amount Sold

$14,740,756

Investors

15

First Sale

Feb 15, 2017

Offering Details

Type
Equity, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2012
Non-Accredited Investors
No

Related Persons

NameRole
Gail Maderis
Related Person
Michael D. Cannon
Related Person
Oranee Daniels
Related Person
Wendee S. Hutton
Related Person
Steven P. James
Related Person
David Kabakoff
Related Person
Vinzenz Ploerer
Related Person
Sarah Walter
Related Person
Raju Gadiraju, Ph.D.
Related Person
Benjamin Rovinski
Related Person

Company

Antiva Biosciences, Inc.

6000 SHORELINE COURT

SOUTH SAN FRANCISCO, CA, 94080

(650) 822-1400

SEC Filing

0001563355-17-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free